These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 25019961)

  • 1. Impact of immune response on the use of iPSCs in disease modeling.
    Zhang Z; Huang B; Gao F; Zhang R
    Curr Stem Cell Res Ther; 2015; 10(3):236-44. PubMed ID: 25019961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reverse engineering human neurodegenerative disease using pluripotent stem cell technology.
    Liu Y; Deng W
    Brain Res; 2016 May; 1638(Pt A):30-41. PubMed ID: 26423934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of human allogeneic and syngeneic pluripotent stem cells and immunological implications for transplantation.
    Sackett SD; Brown ME; Tremmel DM; Ellis T; Burlingham WJ; Odorico JS
    Transplant Rev (Orlando); 2016 Apr; 30(2):61-70. PubMed ID: 26970668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differentiation of blood T cells: Reprogramming human induced pluripotent stem cells into neuronal cells.
    Tsai PH; Chang YC; Lee YY; Ko YL; Yang YH; Lin CF; Chang YL; Yu WC; Shih YH; Chen MT
    J Chin Med Assoc; 2015 Jun; 78(6):353-9. PubMed ID: 26022695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential applications of induced pluripotent stem cells (iPSCs) in the modeling of gastrointestinal disorders.
    Liu S; Zhang D; Chen Y; Wang B; Qiao L
    Curr Stem Cell Res Ther; 2015; 10(3):220-7. PubMed ID: 25723188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of Induction: Induced Pluripotent Stem Cells (iPSCs).
    Singh VK; Kumar N; Kalsan M; Saini A; Chandra R
    J Stem Cells; 2015; 10(1):43-62. PubMed ID: 26665937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of Induced Pluripotent Stem Cells.
    Deyle DR
    Methods Mol Biol; 2021; 2221():71-87. PubMed ID: 32979199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrated analysis of hematopoietic differentiation outcomes and molecular characterization reveals unbiased differentiation capacity and minor transcriptional memory in HPC/HSC-iPSCs.
    Gao S; Hou X; Jiang Y; Xu Z; Cai T; Chen J; Chang G
    Stem Cell Res Ther; 2017 Jan; 8(1):13. PubMed ID: 28114969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential applications of induced pluripotent stem cells (iPSCs) in hepatology research.
    Sun C; Wilson GS; Fan JG; Qiao L
    Curr Stem Cell Res Ther; 2015; 10(3):208-15. PubMed ID: 25599714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integration-free reprogramming of human somatic cells to induced pluripotent stem cells (iPSCs) without viral vectors, recombinant DNA, and genetic modification.
    Heng BC; Fussenegger M
    Methods Mol Biol; 2014; 1151():75-94. PubMed ID: 24838880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolome Profiling of Partial and Fully Reprogrammed Induced Pluripotent Stem Cells.
    Park SJ; Lee SA; Prasain N; Bae D; Kang H; Ha T; Kim JS; Hong KS; Mantel C; Moon SH; Broxmeyer HE; Lee MR
    Stem Cells Dev; 2017 May; 26(10):734-742. PubMed ID: 28346802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reprogramming induced pluripotent stem cells in the absence of c-Myc for differentiation into hepatocyte-like cells.
    Li HY; Chien Y; Chen YJ; Chen SF; Chang YL; Chiang CH; Jeng SY; Chang CM; Wang ML; Chen LK; Hung SI; Huo TI; Lee SD; Chiou SH
    Biomaterials; 2011 Sep; 32(26):5994-6005. PubMed ID: 21658760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficient Generation of Non-Integration and Feeder-Free Induced Pluripotent Stem Cells from Human Peripheral Blood Cells by Sendai Virus.
    Ye H; Wang Q
    Cell Physiol Biochem; 2018; 50(4):1318-1331. PubMed ID: 30355953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An Overview of Direct Somatic Reprogramming: The Ins and Outs of iPSCs.
    Menon S; Shailendra S; Renda A; Longaker M; Quarto N
    Int J Mol Sci; 2016 Jan; 17(1):. PubMed ID: 26805822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular Disease Modeling Using Patient-Specific Induced Pluripotent Stem Cells.
    Tanaka A; Yuasa S; Node K; Fukuda K
    Int J Mol Sci; 2015 Aug; 16(8):18894-922. PubMed ID: 26274955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Derivation of male germ cells from induced pluripotent stem cells by inducers: A review.
    Amini Mahabadi J; Sabzalipoor H; Kehtari M; Enderami SE; Soleimani M; Nikzad H
    Cytotherapy; 2018 Mar; 20(3):279-290. PubMed ID: 29397308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of Naivetropic Induced Pluripotent Stem Cells from Parkinson's Disease Patients for High-Efficiency Genetic Manipulation and Disease Modeling.
    Hu Z; Pu J; Jiang H; Zhong P; Qiu J; Li F; Wang X; Zhang B; Yan Z; Feng J
    Stem Cells Dev; 2015 Nov; 24(21):2591-604. PubMed ID: 26218671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patient-derived induced pluripotent stem cells for models of cancer and cancer stem cell research.
    Chao HM; Chern E
    J Formos Med Assoc; 2018 Dec; 117(12):1046-1057. PubMed ID: 30172452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential of Induced Pluripotent Stem Cells for Use in Gene Therapy: History, Molecular Bases, and Medical Perspectives.
    Fus-Kujawa A; Mendrek B; Trybus A; Bajdak-Rusinek K; Stepien KL; Sieron AL
    Biomolecules; 2021 May; 11(5):. PubMed ID: 34067183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evolution of induced pluripotent stem cell technology.
    Zhou H; Ding S
    Curr Opin Hematol; 2010 Jul; 17(4):276-80. PubMed ID: 20442654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.